SCHEMBL29419599

SCHEMBL29419599

CCc1c2nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)cnc3OCCOC)[nH]c(=O)c2nn1Cc1ccccn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 1.00
PDE6C P51160 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314617 1.00 PDE5A (1.00) PDE5APDE6C
SCHEMBL6443319 0.97 PDE5A (0.94) PDE5APDE6C
SCHEMBL6441919 0.95 PDE5A (0.90) PDE5APDE6C
SCHEMBL3680746 0.95 PDE5A (0.90) PDE5APDE6C
SCHEMBL6446371 0.95 PDE5A (0.90) PDE5APDE6C
SCHEMBL6444669 0.94 PDE5A (0.89) PDE5APDE6C
SCHEMBL2148526 0.94 PDE5A (0.89) PDE5APDE6C
SCHEMBL6446034 0.94 PDE5A (0.89) PDE5APDE6C
SCHEMBL6445340 0.94 PDE5A (0.88) PDE5APDE6C
SCHEMBL3680256 0.93 PDE5A (0.88) PDE5APDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12465605-B2 Methods and materials for gender-dependent treatment of cardiovascular dysfunction MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2025-11-11 US claimed
US-12465605-B2 Methods and materials for gender-dependent treatment of cardiovascular dysfunction MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2025-11-11 US disclosed
US-20220211702-A1 METHODS AND MATERIALS FOR GENDER-DEPENDENT TREATMENT OF CARDIOVASCULAR DYSFUNCTION MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2022-07-07 US disclosed
CN-114144229-A Methods and materials for gender-dependent treatment of cardiovascular dysfunction 梅约医学教育与研究基金会 2022-03-04 CN disclosed
US-20220062307-A1 METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2022-03-03 US disclosed